Chelidonium Composé 3 Ch Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02236428) held by Dolisos Canada Inc., containing Cinchona Officinalis. Health Canada lists its status as Cancelled Post Market (status date 24 Apr 2006). Nexara Health has matched 10 registrations of Cinchona Officinalis across 1 other regulated market, 4 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02236428 |
|---|---|
| Brand name | Chelidonium Composé |
| Active ingredient | Cinchona Officinalis |
| Strength | 3 Ch |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 24 Apr 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Cinchona Officinalis registered in other markets
10 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | China 30C | Energique, Inc. | Liquid | listed | FDA NDC | |
| United States | Cinchona Officinalis 30C | Natural Creations, Inc | Liquid | listed | FDA NDC | |
| United States | DIGESTION Formula | Apex Energetics Inc. | Solution/ Drops | listed | FDA NDC | |
| United States | G06 Enzy-Met | Apex Energetics Inc. | Solution/ Drops | listed | FDA NDC | |
| United States | Bestmade Natural Products China Off | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| United States | Cinchona Officinalis | True Botanica, LLC | Globule | listed | FDA NDC | |
| United States | Cinchona Officinalis | Ohm Pharma Inc. | Pellet | listed | FDA NDC | |
| United States | Cinchona Officinalis | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Pellet | listed | FDA NDC |
See every manufacturer of Cinchona Officinalis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Chelidonium Composé (DIN 02236428) marketed in Canada?
No. Health Canada lists DIN 02236428 as Cancelled Post Market as of 24 Apr 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Cinchona Officinalis registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 1 other market, including 4 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02236428, status date 2006-04-24; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02236428, status date 2006-04-24; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02236428, status date 2006-04-24; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.